Remove 2040 Remove Compliance Remove Treatment
article thumbnail

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update

Cannabis Law Report

” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose. On track to commence Phase 2 proof-of-concept clinical trial with ANEB-001 for the treatment of acute cannabinoid intoxication by year-end. and Arjun Chanmugam, M.D.,

article thumbnail

Bulletin No 22-01: Updated List of Pesticides Allowed in the Production of High THC Cannabis

Cannabis Law Report

Arcus Plant Growth Regulator for Seed Treatment. For information regarding how to comply with the pesticide label, please contact the WSDA Pesticide Compliance. Phone: 360-902-2040. Products Removed from the List: A review found that the labeled uses did not meet WSDA criteria: Type. EPA or WA Registration Number. Merus 3.0*.

THC 52